Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado.
J Infect Dis. 2017 Dec 16;216(suppl_10):S868-S874. doi: 10.1093/infdis/jix434.
Long known to be endemic in Africa and Southeast Asia and a rare cause of acute febrile illness, Zika virus (ZIKAV) arose from obscurity when an Asian genotype ZIKAV caused an outbreak of mild febrile illness in 2007 in Yap State, Federated States of Micronesia. Subsequent viral spread in the Pacific led to a large outbreak in French Polynesia commencing in 2013. After its recognition in the Americas through March 2017, the Pan American Health Organization has received reports of >750000 suspected and laboratory-confirmed cases of autochthonous ZIKAV transmission. Outbreaks in most countries in the Americas peaked in early to mid-2016. Increased surveillance in several Southeast Asian counties has led to increased case recognition, including an outbreak in Singapore, and the first reports of birth defects linked to ZIKAV in the region. As of April 2017, the World Health Organization reported 84 countries or territories with current or previous ZIKAV transmission.
寨卡病毒(ZIKAV)长期以来一直被认为是非洲和东南亚的地方性病毒,是急性发热性疾病的罕见病因,直到 2007 年,一种亚洲基因型寨卡病毒在密克罗尼西亚联邦的雅浦州引起轻度发热性疾病爆发,这种病毒才开始引起人们的关注。随后,太平洋地区的病毒传播导致 2013 年法属波利尼西亚发生大规模疫情。自 2017 年 3 月在美洲得到确认以来,泛美卫生组织已收到超过 75 万例疑似和实验室确诊的本地传播寨卡病毒病例报告。美洲大多数国家的疫情在 2016 年初至年中达到高峰。几个东南亚国家加强了监测,导致病例识别增加,包括新加坡的疫情爆发,以及该地区首次报告与寨卡病毒有关的出生缺陷。截至 2017 年 4 月,世界卫生组织报告称,84 个国家或地区存在当前或过去的寨卡病毒传播。